Ram. Of course there is proof that will satisfy me . Do U think Statins were widely accepted based on their first double blinded placebo controlled Outcome trial ....that there were no follow up studies confirming risk reduction ?
I can find at least 13 independent trials confirming the benefit of Statins ......and no I dont need 13 more trials with Vascepa .
Vascepa is listed as 11b ( 2b ) level of evidence in the EU ....compared to statins which I believe are classified as 1a ( the highest ) Why ? Because of independent trials confirming the risk reduction
Independently confirming the 12 mth post ACS data presented at ACC23 should be no big real using Real World evidence AMRN / Denner needs to do that
Market Data 
Markets 
AI
